Myocardial tissue engineering and heart muscle repair
Related Experiment Video
Updated: May 17, 2026
Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
Published on: October 3, 2014
Bijoy Chandapillai Karikkineth1, Wolfram-Hubertus Zimmermann
1Department of Pharmacology, University Medical Center, Georg-August-University Göttingen, Germany.
Insights
Cardiovascular diseases cause many deaths globally. Stem cell tissue engineering offers a promising approach for cardiac repair, overcoming limitations of current therapies and aiming for clinical translation.
Area of Science:
- Regenerative Medicine
- Biomedical Engineering
- Cardiology
Background:
- Cardiovascular diseases are leading global causes of mortality.
- Current treatments for myocardial infarction and heart failure primarily manage symptoms, failing to reverse underlying pathology.
- Cellular cardiomyoplasty faces challenges including poor cell survival, engraftment, and differentiation.
Purpose of the Study:
- To review therapeutic cells for cardiac repair.
- To discuss current stem cell-based myocardial tissue engineering strategies.
- To outline requirements for translating myocardial tissue engineering into clinical practice.
Main Methods:
- Review of existing literature on stem cell technologies for cardiac repair.
- Analysis of current stem cell-based myocardial tissue engineering approaches.
- Identification of challenges and requirements for clinical translation.
Main Results:
- Stem cell technologies offer potential solutions for cardiomyocyte availability.
- Tissue engineering provides an alternative to cell-based therapies for organ replacement.
- Significant hurdles remain in cell survival, engraftment, and differentiation for effective cardiac repair.
Conclusions:
- Stem cell-based myocardial tissue engineering holds significant potential for treating cardiovascular diseases.
- Overcoming limitations in cell behavior and ensuring successful clinical translation are critical next steps.
- Further research is needed to bridge the gap between experimental concepts and clinical reality for cardiac regeneration.
Abstract:
Cardiovascular diseases, including myocardial infarction and heart failure, are the main causes of death worldwide. Classical pharmacological treatment may halt, but cannot reverse the underlying disease process. Cellular cardiomyoplasty has the potential to reconstruct myocardium in situ; yet, it is hampered by poor cell survival, engraftment, and differentiation. Tissue engineering has emerged as an alternative cell-based approach, aiming at partial or full replacement of damaged organs with in vitro generated tissue equivalents. However, limited availability of therapeutic cardiomyocytes poses a major challenge on cell-based and in particular tissue engineering-based therapies. Rapidly evolving stem cell technologies, enabling mass cultures may overcome this limitation. Translating available experimental concepts into clinical reality will be the ultimate challenge. This review discusses potentially therapeutic cells for cardiac repair, current stem cell-based myocardial tissue engineering strategies, and the requirements for a translation of myocardial tissue engineering into clinical practice.
